Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3420613 | 0.77 | ALDH1A1 (0.39) | MEN1KMT2AALDH1A1MAPTHTT | |
| SCHEMBL818463 | 0.73 | ADRB1 (0.40) | MEN1KMT2AALDH1A1MAPTSLC18A3 | |
| SCHEMBL1950899 | 0.73 | HTT (0.37) | TSHRMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL1950329 | 0.69 | ADRB1 (0.36) | TSHRMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL3162979 | 0.64 | SLC18A3 (0.57) | HSD17B10TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL28188649 | 0.64 | SLC18A3 (0.57) | HSD17B10TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL16727174 | 0.62 | SLC18A3 (0.55) | HSD17B10TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL16141627 | 0.62 | HSD17B10 (0.46) | HSD17B10TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL13292998 | 0.61 | MEN1 (0.57) | TSHRMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL19865053 | 0.60 | SLC18A3 (0.49) | HSD17B10TSHRMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9221042-B2 | Metal complexes, especially the ruthenium complexes, and use thereof | APEIRON SYNTHESIS S.A. (PL) | 2015-12-29 | — | — | US | disclosed |
| US-20150217283-A1 | NOVEL METAL COMPLEXES, ESPECIALLY THE RUTHENIUM COMPLEXES, AND USE THEREOF | APEIRON SYNTHESIS S.A. (PL) | 2015-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150217283-A1 | NOVEL METAL COMPLEXES, ESPECIALLY THE RUTHENIUM COMPLEXES, AND USE THEREOF | ABCB7, AP1M1, NDUFS5 | HSD17B10 344/4885TSHR 4733/4885MEN1 536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.